From video
Interpreted Prediction
The Contract Development and Manufacturing Organization (CDMO) segment within the Indian pharmaceutical sector is of interest, and despite potential US tariffs, India's dependence on this sector provides a degree of protection.
AI Evaluation Notes
The prediction suggests that the Indian CDMO segment has a degree of protection despite potential US tariffs due to US dependence on India. While broad economic shifts are hard to measure in such a complex field, the Indian pharmaceutical industry, including CDMOs, has generally seen continued growth, although specific impacts of US tariffs would require more granular analysis.